MECHANISMS OF ENHANCEMENT OF NATURAL-KILLER ACTIVITY BY AN ANTIBODY TO CD44 - INCREASE CONJUGATE FORMATION AND RELEASE OF TUMOR-NECROSIS-FACTOR-ALPHA

被引:19
作者
TAN, PH [1 ]
LIU, YF [1 ]
SANTOS, EB [1 ]
SANDMAIER, BM [1 ]
机构
[1] UNIV WASHINGTON,SCH MED,SEATTLE,WA 98104
关键词
D O I
10.1006/cimm.1995.1169
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
In this report, we found that an anti-CD44 mAb, S5, augmented conjugate formation between the effector cells (canine PBMC) and an NX-sensitive target cell line [canine thyroid adenoma carcinoma cell line (CTAC)], as determined by two different methods: conjugate enumeration using fluorescence microscopy and two-color flow cytometric analysis. However, no increase in conjugate formation was seen when an NK-resistant target was used. This enhancement of initial conjugate formation could not be blocked using an antibody to CD18 (60.3), indicating that S5 possibly acted through another adhesive molecule(s), But the NK killing activity can be partially blocked by 60.3, indicating that this molecule may be important for later adhesive events, We also found that S5 stimulated the release of a heat labile cytotoxic factor from canine PBMC. This factor was found to lyse only TNF alpha-sensitive targets (CTAC and L929 cell lines) and caused apoptosis in the target cells. Its bioactivity was neutralized by polyclonal antibody to TNF alpha. All of these observations were consistent with the fact that the factor was TNF alpha. Our data suggested that the two mechanisms responsible for the enhancement in canine NK activity by an mAb to CD44 were an increase in conjugate formation and the release of TNF alpha. (C) 1995 Academic Press, Inc.
引用
收藏
页码:255 / 264
页数:10
相关论文
共 62 条
[51]  
SHIMIZU Y, 1989, J IMMUNOL, V143, P2457
[52]  
SVEDERSKY LP, 1984, J IMMUNOL, V133, P714
[53]  
TAN PHS, 1993, J IMMUNOL, V150, P812
[54]  
TIMONEN T, 1988, J IMMUNOL, V141, P1041
[55]  
TIMONEN T, 1982, J IMMUNOL, V128, P2514
[56]  
TOHMA S, 1991, J IMMUNOL, V146, P492
[57]   RESPONSE OF RESTING HUMAN PERIPHERAL-BLOOD NATURAL-KILLER CELLS TO INTERLEUKIN-2 [J].
TRINCHIERI, G ;
MATSUMOTOKOBAYASHI, M ;
CLARK, SC ;
SEEHRA, J ;
LONDON, L ;
PERUSSIA, B .
JOURNAL OF EXPERIMENTAL MEDICINE, 1984, 160 (04) :1147-1169
[58]   MOLECULAR-CLONING OF THE COMPLEMENTARY-DNA FOR HUMAN-TUMOR NECROSIS FACTOR [J].
WANG, AM ;
CREASEY, AA ;
LADNER, MB ;
LIN, LS ;
STRICKLER, J ;
VANARSDELL, JN ;
YAMAMOTO, R ;
MARK, DF .
SCIENCE, 1985, 228 (4696) :149-154
[59]   LFA-3, CD44, AND CD45 - PHYSIOLOGICAL TRIGGERS OF HUMAN MONOCYTE TNF AND IL-1 RELEASE [J].
WEBB, DSA ;
SHIMIZU, Y ;
VANSEVENTER, GA ;
SHAW, S ;
GERRARD, TL .
SCIENCE, 1990, 249 (4974) :1295-1297
[60]   DISSOCIATION OF MEMBRANE-BINDING AND LYTIC ACTIVITIES OF THE LYMPHOCYTE PORE-FORMING PROTEIN (PERFORIN) [J].
YOUNG, JDE ;
DAMIANO, A ;
DINOME, MA ;
LEONG, LG ;
COHN, ZA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 165 (05) :1371-1382